Trial Profile
Pan European Collaboration on Antipsychotic Naïve Schizophrenia II
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Apr 2021
Price :
$35
*
At a glance
- Drugs Aripiprazole (Primary)
- Indications Schizophrenia
- Focus Pharmacodynamics
- Acronyms PECANS II
- 27 Apr 2021 Status changed from active, no longer recruiting to completed.
- 24 Mar 2020 Planned primary completion date changed from 1 Apr 2019 to 1 Aug 2020.
- 24 Mar 2020 Status changed from recruiting to active, no longer recruiting.